Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab

1. Gion, M.
2. García-Mosquera, J.J.
3. Pérez-García, J.M.
4. Peg, V.
5. Ruiz-Borrego, M.
6. Stradella, A.
7. Bermejo, B.
8. Guerrero, J.A.
9. López-Montero, L.
10. Mancino, M.
11. Rodríguez-Morató, J.
12. Antonarelli, G.
13. Sampayo-Cordero, M.
14. Llombart-Cussac, A.
15. Cortés, J.